Erik Ingelsson
Vermogen: 578 145 $ op 31-05-2026
Vermogen: 578 145 $ op 31-05-2026
Erik Ingelsson currently works at Wave Life Sciences Ltd., as Chief Scientific Officer from 2024.
Dr. Ingelsson also formerly worked at GSK Plc, as Senior Vice President & Head-Target Discovery and Stanford University, as Professor-Medicine from 2015 to 2019.
Dr. Ingelsson received his doctorate degree from the University of Uppsala.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 09-04-2026 | 87.864 ( 0,05% ) | 578 145 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| WAVE LIFE SCIENCES LTD. | Hoofd Techniek/Wetenschap/O&O | 09-05-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-2019 |
| GSK PLC | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Wave Life Sciences Ltd.
Wave Life Sciences Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA oligonucleotides medicines | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau